Q/C Technologies, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Q/C Technologies, Inc. (QCLS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $5.37 thousand for the 3-month period ending 2017-09-30, per its 10-Q/A filed 2018-07-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2018-07-13
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-09-30 was $5.37K.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2016-09-30 was $0.00.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2016-06-30 was $0.00.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2015-12-31 was $54.14K.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2015 was $54.14K, a 90.15% decline from fiscal 2014.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2014 was $549.60K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month as first filed |
|---|---|---|---|---|---|
| 2017-09-30 | $5.37K 10-Q/A · filed 2018-07-13 | $15.78K 10-Q/A · filed 2018-07-13 | |||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $35.42K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | $54.14K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $54.14K derived: sum of 2 quarters · filed 2016-11-14 | $54.14K derived: sum of 3 quarters · filed 2016-11-14 | $54.14K 10-K · filed 2016-03-30 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $549.60K 10-K · filed 2016-03-30 | $549.00K 10-K · filed 2015-03-23 | ||
| 2014-09-30 | $549.60K 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |